SCHEMBL5163362

SCHEMBL5163362

Cc1nc(C(F)(F)F)c(C(=O)Nc2ccccc2I)s1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.54
SMN1; SMN2 Q16637 3/20 0.51
KDM4E B2RXH2 1/20 0.51
HTT P42858 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
GAA P10253 1/20 0.50
ALDH1A1 P00352 1/20 0.46
RAB9A P51151 3/20 0.46
RECQL P46063 1/20 0.46
KMT2A Q03164 5/20 0.43
MEN1 O00255 3/20 0.43
HSD11B1 P28845 1/20 0.42
POLB P06746 1/20 0.42
NPC1 O15118 2/20 0.40
NTRK1 P04629 1/20 0.40
LMNA P02545 1/20 0.40
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23367943 0.88 MAPT (0.55) MAPTSMN1; SMN2KDM4EHTTTDP1
SCHEMBL23367944 0.87 MEN1 (0.56) MAPTSMN1; SMN2KDM4EHTTTDP1
SCHEMBL5165086 0.86 MAPT (0.53) MAPTSMN1; SMN2KDM4EHTTTDP1
SCHEMBL21652164 0.85 MAPT (0.52) MAPTSMN1; SMN2KDM4EHTTTDP1
SCHEMBL9225609 0.84 MAPT (0.54) MAPTSMN1; SMN2KDM4EHTTTDP1
SCHEMBL7787348 0.84 MAPT (0.51) MAPTSMN1; SMN2KDM4EHTTTDP1
SCHEMBL7458241 0.82 MAPT (0.49) MAPTSMN1; SMN2KDM4EHTTTDP1
SCHEMBL13210783 0.81 NTRK1 (0.51) MAPTSMN1; SMN2KDM4EHTTTDP1
SCHEMBL12212660 0.80 MAPT (0.54) MAPTSMN1; SMN2KDM4EHTTTDP1
SCHEMBL978883 0.80 MAPT (0.47) MAPTSMN1; SMN2KDM4EHTTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1474406-B1 DISUBSTITUTED THIAZOLYL CARBOXANILIDES AND THEIR USE AS MICROBICIDES BAYER CROPSCIENCE AG (DE) 2007-03-21 EP disclosed
US-7098227-B2 Disubstituted thiazolyl carboxanilides and their use as microbicides BAYER CROPSCIENCE AG (DE) 2006-08-29 US disclosed
US-20050143428-A1 Disubstituted thiazolyl carboxanilides and their use as microbicides BAYER INTELLECTUAL PROPERTY GMBH (DE) 2005-06-30 US disclosed
EP-1474406-A1 DISUBSTITUTED THIAZOLYL CARBOXANILIDES AND THEIR USE AS MICROBICIDES Bayer CropScience Aktiengesellschaft (DE) 2004-11-10 EP disclosed
WO-2003066609-A1 DISUBSTITUTED THIAZOLYL CARBOXANILIDES AND THEIR USE AS MICROBICIDES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2003-08-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143428-A1 Disubstituted thiazolyl carboxanilides and their use as microbicides CX3CR1, MSR1, CD209 MAPT 4122/4885SMN1; SMN2 4808/4885KDM4E 3217/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.